Investors Purchase Large Volume of Tempus AI Call Options (NASDAQ:TEM)

Tempus AI, Inc. (NASDAQ:TEM) saw some unusual options trading on Wednesday. Investors acquired 72,944 call options on the stock. This represents an increase of 46% compared to the average volume of 50,068 call options.

Insider Buying and Selling at Tempus AI

In other Tempus AI news, Director Nadja West sold 809 shares of the company’s stock in a transaction dated Tuesday, March 4th. The shares were sold at an average price of $51.11, for a total transaction of $41,347.99. Following the transaction, the director now directly owns 37,705 shares in the company, valued at approximately $1,927,102.55. This represents a 2.10 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, Director Wayne A.I. Frederick sold 3,000 shares of the company’s stock in a transaction that occurred on Monday, March 31st. The stock was sold at an average price of $45.54, for a total value of $136,620.00. Following the completion of the sale, the director now owns 26,514 shares in the company, valued at approximately $1,207,447.56. This represents a 10.16 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 4,237,561 shares of company stock worth $251,210,331. 27.60% of the stock is currently owned by insiders.

Hedge Funds Weigh In On Tempus AI

Institutional investors have recently made changes to their positions in the business. ARK Investment Management LLC increased its stake in Tempus AI by 132.1% during the fourth quarter. ARK Investment Management LLC now owns 5,519,644 shares of the company’s stock valued at $186,343,000 after acquiring an additional 3,141,487 shares during the period. Sumitomo Mitsui Trust Group Inc. increased its position in shares of Tempus AI by 166.0% during the fourth quarter. Sumitomo Mitsui Trust Group Inc. now owns 3,239,093 shares of the company’s stock valued at $109,352,000 after purchasing an additional 2,021,394 shares during the period. Nikko Asset Management Americas Inc. raised its stake in shares of Tempus AI by 166.0% in the fourth quarter. Nikko Asset Management Americas Inc. now owns 3,239,093 shares of the company’s stock valued at $109,352,000 after purchasing an additional 2,021,394 shares in the last quarter. Franklin Resources Inc. lifted its position in Tempus AI by 240.5% in the fourth quarter. Franklin Resources Inc. now owns 2,762,173 shares of the company’s stock worth $93,251,000 after purchasing an additional 1,950,862 shares during the period. Finally, JPMorgan Chase & Co. boosted its stake in Tempus AI by 86,947.2% during the fourth quarter. JPMorgan Chase & Co. now owns 1,653,896 shares of the company’s stock worth $55,836,000 after buying an additional 1,651,996 shares in the last quarter. 24.22% of the stock is currently owned by institutional investors.

Tempus AI Stock Up 11.0 %

Shares of NASDAQ:TEM opened at $65.22 on Friday. The company has a 50 day moving average price of $48.22 and a 200 day moving average price of $50.87. The company has a debt-to-equity ratio of 8.17, a quick ratio of 2.55 and a current ratio of 2.69. Tempus AI has a 1-year low of $22.89 and a 1-year high of $91.45.

Tempus AI (NASDAQ:TEM) last posted its quarterly earnings results on Tuesday, May 6th. The company reported ($0.24) EPS for the quarter, topping the consensus estimate of ($0.27) by $0.03. The company had revenue of $255.74 million for the quarter, compared to analyst estimates of $248.13 million. The business’s quarterly revenue was up 75.4% compared to the same quarter last year. As a group, equities analysts forecast that Tempus AI will post -6.15 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several analysts have recently commented on TEM shares. William Blair reiterated a “market perform” rating on shares of Tempus AI in a research report on Tuesday, February 25th. Morgan Stanley upped their target price on shares of Tempus AI from $50.00 to $60.00 and gave the company an “overweight” rating in a report on Thursday, March 6th. BTIG Research initiated coverage on shares of Tempus AI in a report on Monday, April 21st. They set a “buy” rating and a $60.00 price target for the company. Loop Capital lowered their target price on shares of Tempus AI from $57.00 to $52.00 and set a “buy” rating for the company in a research note on Tuesday, January 14th. Finally, JPMorgan Chase & Co. lowered Tempus AI from an “overweight” rating to a “neutral” rating and increased their price target for the stock from $50.00 to $55.00 in a research note on Tuesday, February 25th. Six research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. According to MarketBeat, Tempus AI currently has an average rating of “Moderate Buy” and an average target price of $61.08.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.